Published: August 16, 2011
OneWorld Health Announces the Addition of Paromomycin to National Essential Medicines List by the Government of Nepal
SOUTH SAN FRANCISCO, Calif. - (BUSINESS WIRE) - OneWorld Health (OWH), a non-profit that develops lifesaving medicine
for neglected diseases announced that its antibiotic paromomycin (PMIM)
a life-saving medicine for the treatment of Kala-Azar (black fever), has
been approved for the Essential Drug List of Nepal. This milestone
signifies a major vote of confidence from the Nepali government and will
move PMIM towards being adopted into the public healthcare system.
Kala-Azar is a life-threatening parasitic disease also known as visceral
leishmaniasis (VL). It is nearly 100% fatal without treatment, and
affects up to 500,000 people annually, mostly in poor countries in South
Asia, East Africa and South America. OWH resurrected PMIM, a drug
abandoned by for-profit pharmaceutical companies, and developed it into
a safe, effective and low-cost treatment for Kala-Azar.
"Kala-Azar was an international tragedy, with patients in impoverished
countries needlessly dying of this disease because of lack of an
affordable drug. With paromomycin, which is not only safe and effective
but affordable to even the poorest patients, OWH has already saved
thousands of lives worldwide," said Richard Chin, MD and CEO of OWH.
Headquartered in South San Francisco, OneWorld Health is a non-profit
that discovers, develops and delivers safe, effective and affordable new
medicines for impoverished patients, especially children, suffering from
neglected diseases in the developing world. More information can be
found here: www.oneworldhealth.org.
OneWorld Health
Alyson Chadwick, 202-480-0259
achadwick@thehaloproject.com
Copyright © 2012, Business Wire, Inc., All rights reserved.
Copyright © 2012, NewsBlaze,
Daily News
Search News
